Associate Professor
McMaster University
Hamilton, Ontario, Canada
I am a clinician-scientist with an MD in Endocrinology and a PhD in Epidemiology and Genetics. I am appointed Associate Professor in the Department of Medicine (Endocrinology Division), and also serve as a Scientist at the Population Health Research Institute (PHRI) in Hamilton.
My research program focuses on the integration of genetics, proteomics, epidemiology, and statistics to study the mechanisms underlying obesity, diabetes, and their vascular complications. Specifically, I analyze circulating biomarkers to investigate biological pathways involved in cardiometabolic diseases across the lifespan; address methodological challenges in high-throughput omics analyses; integrate proteomic and genomic data using Mendelian Randomization to explore causal relationships between biomarkers and disease outcomes.
As a clinician, I provide routine outpatient and inpatient consultations in lipids, diabetes, and general endocrinology, where I integrate my expertise in genetics to enhance patient care. I play an active role in the management of individuals with early-onset or severe cardiometabolic diseases in which a genetic component is strongly suspected, such as severe dyslipidemia (familial hypercholesterolemia, hypertriglyceridemia), familial partial lipodystrophy, premature cardiovascular disease, and atypical forms of diabetes. I am deeply committed to the integration of genetic and biomarker data into clinical practice, with the goal of improving diagnostic accuracy, enabling personalized care, expanding therapeutic options, and refining prognostic insights in rare cardiometabolic disorders. This represents a unique area of expertise at the intersection of clinical endocrinology and precision medicine.
Disclosure(s): I do not have a relationship with a for-profit and/or a not-for-profit organization to disclose
CSEMS4 - Dyslipidemia: Interpretation of genetic reports
Friday, November 28, 2025
16:00 - 17:15 Toronto